CLPTClearPoint Neuro, Inc.

$10.48-60% 1Y

Is the price fair?

What CLPT's price assumes

ClearPoint Neuro, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 6.72× revenue.

6.72

Price / sales · no P/E: the last twelve months did not end in a profit

Price / book
14.5

Price / book · as of 2026-Q1

EV / sales
7.41

EV / sales

Details›
Price / bookas of 2026-Q1
14.5
EV / EBIToperating margin −73%: the multiple describes the denominator
not meaningful
EV / salesas of 2026-Q1
7.41
Market capitalisation
$314M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.